Knowledge Distillery

New treatments are needed to reduce the risk of progression of coronavirus disease 2019 (COVID-19). Molnupiravir is an oral, small-molecule antiviral…

Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe coronavirus disease 2019 (COVID-19). Whether the use of…

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Early High-Titer Plasma Therapy to Prevent Severe COVID-19 in Older Adults

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil,…

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19

Efficacy of Tocilizumab in Patients Hospitalized with COVID-19

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19

A Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19

Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial